Featured Publication
Title Author(s)
Clinical and Economic Outcomes Attributable to Health Care–Associated Sepsis and Pneumonia
Michael R. Eber, BSE
Ramanan Laxminarayan, PhD, MPH
Eli N. Perencevich, MD, MS
Anup Malani, PhD, JD
Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006
Marc S. Hoffmann, MD
Michael R. Eber, BSE
Ramanan Laxminarayan, PhD, MPH
Community-associated Methicillin- Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006 Eili Klein, David L. Smith, and Ramanan Laxminarayan
Flu and Antibiotic Overprescription Hellen Gelband
Battling Resistance to Antibiotics and Pesticides: An Economic Approach Ramanan Laxminarayan, editor
A Shot Against MRSA? Hellen Gelband
The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004
Rebecca Reik
Fred C. Tenover
Eili Klein
L. Clifford McDonald
Extending the CurePolicy Responses to the Growing Threat of Antibiotic Resistance
Ramanan Laxminarayan
Anup Malani
Antibiotic OveruseThe Influence of Social Norms
The McDonnell Norms Group
Ramanan Laxminarayan
Anup Malani et al.
The Antibiotic Pipeline Abigail Colson
Which MRSA is it? Abigail Colson
Legislative Roundup for 2007 Abigail Colson
Counting MRSA CasesAn Evaluation of Recent Evidence Abigail Colson
The States Take ActionHospital Infection Reporting and Control Abigail Colson
Can Vaccines Reduce Antibiotic Use?The Successes and Challenges of Pneumococcal Vaccines Sarah Darley